Table 1.
IMPT | VMAT | P‐value | |
---|---|---|---|
Patient number | 19 | 16 | |
Age at treatment (yr) | 0.79 | ||
Median (range) | 71 (54–84) | 71 (55–83) | |
Gender | 0.42* | ||
Male, No. (%) | 14 (73.7) | 14 (87.5) | |
Body mass (kg) | 0.55 | ||
Median (range) | 83.2 (53.8–123.0) | 82.5 (69.9–111.3) | |
CTVhigh volume (cm3) | 0.40 | ||
Median (range) | 205.0 (117.6–515.6) | 219.0 (102.5–531.4) | |
CTVlow volume (cm3) | 0.98 | ||
Median (range) | 440.00 (151.8–1144.7) | 447.10 (140.9–773.8) | |
Motion amplitude (mm) | 0.91 | ||
Median (range) | 8 (4–13) | 6.2 (6–13.7) |
CTV, clinical target volume.
P‐value from Fisher's exact test. Others are P‐values from Wilcoxon rank‐sum test.